ATE185275T1 - Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren - Google Patents

Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren

Info

Publication number
ATE185275T1
ATE185275T1 AT92919588T AT92919588T ATE185275T1 AT E185275 T1 ATE185275 T1 AT E185275T1 AT 92919588 T AT92919588 T AT 92919588T AT 92919588 T AT92919588 T AT 92919588T AT E185275 T1 ATE185275 T1 AT E185275T1
Authority
AT
Austria
Prior art keywords
wide range
stimulate
determinants
against hiv
responses against
Prior art date
Application number
AT92919588T
Other languages
English (en)
Inventor
Jay A Berzofsky
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE185275T1 publication Critical patent/ATE185275T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92919588T 1991-08-29 1992-08-31 Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren ATE185275T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75199891A 1991-08-29 1991-08-29

Publications (1)

Publication Number Publication Date
ATE185275T1 true ATE185275T1 (de) 1999-10-15

Family

ID=25024412

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92919588T ATE185275T1 (de) 1991-08-29 1992-08-31 Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren

Country Status (9)

Country Link
EP (1) EP0601108B1 (de)
JP (1) JPH07501516A (de)
AT (1) ATE185275T1 (de)
AU (1) AU665023B2 (de)
CA (1) CA2114849C (de)
DE (1) DE69230106T2 (de)
DK (1) DK0601108T3 (de)
ES (1) ES2257733T3 (de)
WO (1) WO1993004697A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294322B1 (en) * 1988-01-26 2001-09-25 The United States Of America As Represented By The Department Of Health And Human Services Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
WO1995003067A1 (en) * 1993-07-21 1995-02-02 Khavinson Vladimir Khatskelevi Pharmaceutical with immunomodulating activity
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
US5972339A (en) * 1997-11-13 1999-10-26 The General Hospital Corporation Method of eliciting anti-HIV-1 helper T cell responses
MXPA02007478A (es) 2000-02-04 2004-08-23 Univ Duke Vacuna contra el virus de inmunodeficiencia humana.
CN110349627B (zh) * 2019-06-27 2021-08-27 杭州纽安津生物科技有限公司 多肽疫苗序列的设计方法及其自动化设计产品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030449A (en) * 1988-07-21 1991-07-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthetic vaccine against AIDS virus
DE3787002T2 (de) * 1986-12-30 1993-11-25 Us Health Synthetische Peptide, die zelluläre Immunität gegen den AIDS-Virus und dessen Proteine erzeugen.
ES2102347T3 (es) * 1987-02-20 1997-08-01 Genentech Inc Metodos y composiciones para la utilizacion de polipeptidos env y anticuerpos anti-env de hiv.
WO1989002277A2 (en) * 1987-08-28 1989-03-23 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
ES2080047T3 (es) * 1987-11-24 1996-02-01 Abbott Lab Peptidos hiv y metodos para la deteccion de hiv.
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
US4943628A (en) * 1988-06-13 1990-07-24 Ortho Pharmaceutical Corporation HIV peptide-inducted T cell stimulation
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
CA2078545A1 (en) * 1990-04-03 1991-10-04 Timothy J. Gregory Hiv envelope polypeptides
FI931393L (fi) * 1990-09-27 1993-03-26 Syntello Vaccine Dev Kb Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus

Also Published As

Publication number Publication date
JPH07501516A (ja) 1995-02-16
AU2569392A (en) 1993-04-05
DK0601108T3 (da) 2000-04-17
EP0601108A1 (de) 1994-06-15
DE69230106T2 (de) 2000-03-30
DE69230106D1 (de) 1999-11-11
WO1993004697A1 (en) 1993-03-18
EP0601108B1 (de) 1999-10-06
ES2257733T3 (es) 2006-08-01
CA2114849C (en) 2007-04-24
AU665023B2 (en) 1995-12-14
EP0601108A4 (en) 1997-03-19
CA2114849A1 (en) 1993-03-18

Similar Documents

Publication Publication Date Title
GB2255093A (en) Hiv-1 core protein fragments
DE69233772D1 (de) T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
DK0538300T3 (da) O-Glycosyleret IFN-alfa
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
GB9022190D0 (en) Immunogenic material
FI881418A7 (fi) Synteettiset peptidiantigeenit HIV-1 -infektion toteamiseksi.
FI913476A7 (fi) Konjugaattirokotteita, jotka sisältävät immunogeenista proteiinia, HIV-tyyppisiä peptidejä ja anionisia ryhmiä
NO941370L (no) Rekombitope peptider
ATE210721T1 (de) Verwendung eines mbp peptides zur herstellung eines medikamentes für die behandlung von multipler sclerose
ATE185275T1 (de) Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren
DE3685917D1 (de) Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
DE69007571D1 (de) Peptidfragmente von HIV.
MX9101275A (es) Proteina gp160 del virus de inmunodeficiencia humana y composiciones para vacuna que contiene a la misma o a su derivado
SE8803062D0 (sv) Sequential polypeptides endowed with immunological activity
ES2194008T3 (es) Proteina p100 del virus del herpes humano tipo 6, las correspondientes secuencias de adn, su preparacion y uso.
AR020852A1 (es) Antigenos de vacuna de leptospira para la prevencion de leptospirosis
FI885797A7 (fi) Peptidejä, menetelmä niiden valmistamiseksi, niiden käyttö vasta-aineiden valmistamiseksi, sekä näiden käyttö ihmisen veren PAI-1-aktiivisuuden estämiseksi
DE69122850D1 (de) Konformationsepitope des humanen Immundefizienzvirus-Hüllprotein-gp120
IT1233419B (it) Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
FI883735A7 (fi) Ihmisen immuunikatoviruksen, tyyppi 1, antigeenien valmistus ja käyttö diagnostisena ja terapeuttisena välineenä
MX9200711A (es) Un antigeno de fases sanguineas de plasmodium falciparum su preparacion y utilizacion.
ZA88310B (en) Peptides capable of being recognized by antibodies induced against human immunodeficiency retrovirus(hiv-virus),their applications for diagnosis of infections caused by some of these viruses and,in case,to vaccination against aids
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
DE3853832D1 (de) Htlv-i-peptid-antigen und testverfahren.